Home-Based System Relieves Cirrhosis Refractory Ascites
|
By HospiMedica International staff writers Posted on 11 Jan 2022 |
|
Image: An ascites patient with abdominal paracentesis scars (Photo courtesy of iStock)
A novel tunneled peritoneal catheter (PeCa) drainage system provided significant relief for patients with refractory ascites, according to a new study.
The PeCa implant, developed at Hannover Medical School (Germany), is composed of internal shut that lies in the peritoneal cavity, a tunneled section that passes through subcutaneous tissue, and an external port to which drainage bags are connected. To test system efficacy, outcomes in 152 patients with refractory ascites, who were not candidates for transjugular intrahepatic portosystemic shunt (TIPS) and received a PeCa implant, were compared to 71 patients who received standard care, which included repeated large volume paracentesis and albumin.
The results revealed that factors associated with 90-day survival were PeCa implantation, and each point of Model for End-Stage Liver Disease (MELD) score. Hospitalizations were more common in the PeCa group, for reasons that included spontaneous bacterial peritonitis (SBP), hyponatremia, and infections other than SBP. There was no significant difference in mortality between the two groups, but there were trends in the PeCa group towards higher frequency of acute kidney injury (AKI). The study was presented at the American Association for the Study of Liver Diseases annual conference, held online during November 2021.
“Patients with refractory ascites have a very high risk for rehospitalization, AKI, and death. Our data indicate that PeCa could be a valuable new treatment option for patients with refractory ascites and contraindication for TIPS,” said study co-author and presenter Tammo Lambert Tergast, MD. “I think if we can optimize the treatment after discharge, we can also minimize the rehospitalization in these patients. However, the risk for hyponatremia and AKI has to be considered and further explored.”
Refractory ascites occurs when patients no longer respond to medical therapy, a condition that affects over 100,000 patients in Europe and the United States every year, a number that is growing at approximately 10% a year. The primary treatment for ascites is paracentesis, a procedure in which a large bore needle is inserted into the patient's abdomen to remove between 5‐10 liters of ascites that has accumulated over a period of a week or two.
Related Links:
Hannover Medical School
The PeCa implant, developed at Hannover Medical School (Germany), is composed of internal shut that lies in the peritoneal cavity, a tunneled section that passes through subcutaneous tissue, and an external port to which drainage bags are connected. To test system efficacy, outcomes in 152 patients with refractory ascites, who were not candidates for transjugular intrahepatic portosystemic shunt (TIPS) and received a PeCa implant, were compared to 71 patients who received standard care, which included repeated large volume paracentesis and albumin.
The results revealed that factors associated with 90-day survival were PeCa implantation, and each point of Model for End-Stage Liver Disease (MELD) score. Hospitalizations were more common in the PeCa group, for reasons that included spontaneous bacterial peritonitis (SBP), hyponatremia, and infections other than SBP. There was no significant difference in mortality between the two groups, but there were trends in the PeCa group towards higher frequency of acute kidney injury (AKI). The study was presented at the American Association for the Study of Liver Diseases annual conference, held online during November 2021.
“Patients with refractory ascites have a very high risk for rehospitalization, AKI, and death. Our data indicate that PeCa could be a valuable new treatment option for patients with refractory ascites and contraindication for TIPS,” said study co-author and presenter Tammo Lambert Tergast, MD. “I think if we can optimize the treatment after discharge, we can also minimize the rehospitalization in these patients. However, the risk for hyponatremia and AKI has to be considered and further explored.”
Refractory ascites occurs when patients no longer respond to medical therapy, a condition that affects over 100,000 patients in Europe and the United States every year, a number that is growing at approximately 10% a year. The primary treatment for ascites is paracentesis, a procedure in which a large bore needle is inserted into the patient's abdomen to remove between 5‐10 liters of ascites that has accumulated over a period of a week or two.
Related Links:
Hannover Medical School
Gold Member
12-Channel ECG
CM1200B
Digital Radiography System (Ceiling Free)
Digix CF Series
New
Gold Member
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Latest Patient Care News
- AI Avatar Doctor Improves Patient Understanding Before Radiotherapy
- Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
- Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
- VR Training Tool Combats Contamination of Portable Medical Equipment
- Portable Biosensor Platform to Reduce Hospital-Acquired Infections
- First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
- Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
- Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
- Next Gen ICU Bed to Help Address Complex Critical Care Needs
- Groundbreaking AI-Powered UV-C Disinfection Technology Redefines Infection Control Landscape
- Clean Hospitals Can Reduce Antibiotic Resistance, Save Lives
- Smart Hospital Beds Improve Accuracy of Medical Diagnosis
- New Fast Endoscope Drying System Improves Productivity and Traceability
- World’s First Automated Endoscope Cleaner Fights Antimicrobial Resistance
- Portable High-Capacity Digital Stretcher Scales Provide Precision Weighing for Patients in ER
- Portable Clinical Scale with Remote Indicator Allows for Flexible Patient Weighing Use
Channels
Artificial Intelligence
view channel
AI Improves Bronchoscopic Navigation to Difficult-to-Reach Lung Lesions
Lung cancer is a leading cause of cancer mortality, and early detection improves survival. Reaching small, peripheral lung tumors for biopsy remains difficult because bronchoscopic navigation depends on... Read more
Collaborative AI System Improves Medical Diagnostic Accuracy
Hospitals face a persistent trade-off when deploying artificial intelligence for diagnosis. Broad “generalist” models handle many tasks but often lack disease-specific precision. Narrow “specialist” models... Read more
Critical Care
view channel
Adaptive Pulse Oximeter Improves Oxygen Measurement Across Skin Tones
Standard pulse oximeters can misread blood oxygen saturation in people with darker skin because melanin affects how light is absorbed and reflected. This can contribute to occult hypoxemia, in which dangerously... Read more
Wearable Sweat Test Simplifies Cystic Fibrosis Diagnosis
Cystic fibrosis is a genetic disease that disrupts digestion and breathing. Diagnosis depends on sweat chloride testing that is typically limited to accredited centers and specialized laboratories.... Read more
Surgical Techniques
view channel
New Light-Activated Platform Advances Glioblastoma Surgery and Postoperative Treatment
Glioblastoma, an aggressive primary brain tumor, infiltrates healthy tissue and resists complete surgical removal. Residual microscopic disease and the blood–brain barrier limit the effectiveness of adjuvant... Read more
Dual-Energy Mapping and Ablation Catheter Receives CE Mark for Ventricular Arrhythmias
Ventricular arrhythmias, including ventricular tachycardia and premature ventricular complexes, can be life-threatening and often occur in patients with advanced heart disease. Although catheter ablation... Read more
Medical Imaging
view channel
MRI-Guided Ultrasound Method Advances Targeted Treatment of Gliomas
Gliomas, the most common primary brain tumors in adults, include glioblastoma, the deadliest form of brain cancer. Drug delivery is hampered by the brain’s blood-brain barrier, limiting treatment efficacy... Read more
AI Accelerates Individualized Dosimetry for Prostate Cancer Treatment
Radiopharmaceutical therapy is an injected cancer treatment that delivers radiation through the body while selectively targeting tumors. In prostate cancer, current dosing remains largely uniform despite... Read more
Health IT
view channel
Digital Symptom Monitoring Supports More Personalized Breast Cancer Care
Metastatic breast cancer, in which tumors spread to other organs, is incurable but increasingly managed with modern systemic therapies. As more treatments shift from hospital infusions to oral or at-home... Read more
Short Digital Training Program Improves Motor Function in Parkinson’s Disease
Parkinson's disease causes motor symptoms that interfere with movement and daily activities. Drug treatment is standard care, yet additional approaches are needed to target motor control.... Read more
Point of Care
view channel
Rapid Onsite Testing Reduces Emergency Department Transfers in Long-Term Care
Respiratory infections in long-term care residents frequently trigger emergency department transfers that strain hospital capacity and expose frail patients to additional risks. Turnaround delays from... Read more
New Brain Ultrasound Platform Enables Bedside Postoperative Imaging
Transporting postoperative patients for CT or MRI can create operational burdens, delays, and disruptions in care. Bedside visualization may help reduce transport demands, lower radiation exposure, and... Read more
Business
view channel
AI Software Combines Nodule Detection and Diagnosis for Lung Cancer Screening
Lung cancer remains the leading cause of cancer mortality, and screening programs rely on computed tomography to identify disease earlier when curative treatment is more likely. High patient volumes and... Read more
